Tag Archive for: gene therapy

Last year, Evotec expanded its oligonucleotide manufacturing and analysis capabilities at its Verona site.Evotec SE
gene therapy

SynaptixBio Ltd and Evotec SE expand collaboration

Evotec SE is widening its 2022 R&D collaboration SynaptixBio Ltdi to optimise and identify new antisense oligonucleotides to treat children with H-ABC leukodystrophy, a rare genetic myelin synthesis defect that shows similar symptoms such as multiple sclerosis.

Read more
Fundus of patient with teinitis pigmentosa. © By Christian Hamel - wikimedia.org
Ophthalmology

Three companies launch gene therapy alliance for eye diseases

AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.

Read more
In future, gene vectors for novel gene therapies will be developed and produced for clinical trials on an industrial scale by around 100 employees in the new gene therapy development centre at Roche in Penzberg, which covers around 2,500 square metres. © Roche
gene therapy

Roche opens €90m gene therapy development centre

Basel-headquartered Roche AG has inaugurated a brand new €90m gene therapy development centre in Penzberg near Munich.

Read more
© MIP Discovery
gene therapy

Gene therapy supplier MIP Discovery closes £7M Series A financing

MIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy.

Read more
AskBio Europe headquarternatnRoslin Innovation Centre/Easter Bush Campus. © Ask Bio Inc
gene therapy

Bayer’s Ask Bio unit starts Phase II heart failure gene therapy

Bayer SE subsidiary Asklepios BioPharmaceutical Inc. (AskBio) has started Phase II testing of AB-1002 (NAN-101) in patients with congestive heart failure. 

Read more